GSH Group

Rio De Janeiro, Brazil Founded: 1979 • Age: 47 yrs Acquired By CVC
Provider of hemotherapy and cell therapy services for hospitals and clinics

About GSH Group

GSH Group is a Healthcare company based in Rio De Janeiro (Brazil) founded in 1979, and was acquired by CVC in April 2025. Provider of hemotherapy and cell therapy services for hospitals and clinics. Its website grupogsh.com draws about 12 thousand monthly visits. GSH Group offers products and services including Transfusion Medicine, Outpatient Transfusion, Cell Therapy, and Transplants. Its focus areas include Services for Healthcare Providers, BPO and Outsourced Clinical Services. Its legal entity is GRUPO GSH.

Company details

GSH Group was founded in 1979 within the healthcare sector. Hemotherapy and cell therapy services are supplied to hospitals and clinics, focusing on specialized medical support. Operations involve the delivery of these therapies to aid patient treatments across various facilities. The company maintains a role in advancing hemotherapy practices and cell-based interventions for clinical use, without specified geographic limitations.

  • Headquarters Rio De Janeiro, Brazil
  • Stage Acquired
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website grupogsh.com
  • Social LinkedIn Facebook Instagram
  • Acquired by CVC (Apr 2025)
  • Legal Name Grupo Gsh
Key Metrics

Products & Services of GSH Group

GSH Group offers a comprehensive portfolio of products and services, including Transfusion Medicine, Outpatient Transfusion, Cell Therapy, and Transplants.

Transfusion Medicine
Medical Service

Provides blood banks and transfusion agencies for hospital support.

Outpatient Transfusion
Medical Service

Offers safe transfusions in outpatient settings for patients.

Cell Therapy
Therapeutic Service

Delivers cell-based treatments for various medical procedures.

Transplants
Medical Service

Supports transplant demands with specialized hemotherapy expertise.

Investors in GSH Group

GSH Group has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include CVC.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
Mezzanine financing and equity investments are provided by CVC.
1981cvc.comNew York, United States
Premium access

Investor details for GSH Group

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Timeline of GSH Group

2 dated milestones of GSH Group across 46 years, from founding to its latest funding, stage changes and deals.

  1. Founded GSH Group is founded.
  2. Exit Acquired by CVC.

Web traffic of GSH Group

The website of GSH Group (grupogsh.com) receives about 11.8K visits a month.

  • Monthly visits
    11.8K

    ▲ 28.8% vs previous month

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about GSH Group

GSH Group was founded in 1979.

GSH Group is headquartered in Rio De Janeiro, Brazil. It is registered at Rio De Janeiro, Rio De Janeiro, Brazil.

GSH Group was founded in 1979 within the healthcare sector. Hemotherapy and cell therapy services are supplied to hospitals and clinics, focusing on specialized medical support. Operations involve the delivery of these therapies to aid patient treatments across various facilities. The company maintains a role in advancing hemotherapy practices and cell-based interventions for clinical use, without specified geographic limitations.

GSH Group offers Transfusion Medicine, Outpatient Transfusion, Cell Therapy, and Transplants.

GSH Group has 1 investor. Key investors include CVC.

GSH Group operates through Grupo Gsh.

Yes. GSH Group was acquired by CVC in April 2025.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available